UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 


 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of The Securities Exchange Act Of 1934

 

Date of Report (Date of earliest event reported): May 5, 2015

 


 

BRISTOL-MYERS SQUIBB COMPANY

(Exact Name of Registrant as Specified in its Charter)

 


 

Delaware

 

1-1136

 

22-0790350

(State or Other

 

(Commission File

 

(IRS Employer

Jurisdiction of

 

Number)

 

Identification

Incorporation)

 

 

 

Number)

 

345 Park Avenue

New York, NY 10154

(Address of Principal Executive Office)

 

Registrant’s telephone number, including area code: (212) 546-4000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

(a) The Annual Meeting of the Company was held on May 5, 2015.

 

(b) Stockholders voted on the matters set forth below.

 

Item 1. The stockholders elected each of the Company’s 11 nominees to serve as directors of the Company until the 2016 Annual Meeting based upon the following votes:

 

 

 

 

 

 

 

 

 

Broker

 

 

 

For

 

Against

 

Abstain

 

Non-Vote

 

Lamberto Andreotti

 

1,183,408,596

 

14,031,996

 

5,258,859

 

264,171,045

 

Giovanni Caforio, M.D.

 

1,185,168,571

 

12,257,208

 

5,273,672

 

264,171,045

 

Lewis B. Campbell

 

1,134,269,969

 

62,353,065

 

6,076,417

 

264,171,045

 

Laurie H. Glimcher, M.D.

 

1,153,022,959

 

44,043,262

 

5,633,230

 

264,171,045

 

Michael Grobstein

 

1,132,657,825

 

63,811,860

 

6,229,766

 

264,171,045

 

Alan J. Lacy

 

1,166,548,184

 

30,698,725

 

5,452,542

 

264,171,045

 

Thomas J. Lynch, Jr., M.D.

 

1,186,200,778

 

11,017,863

 

5,480,810

 

264,171,045

 

Dinesh C. Paliwal

 

1,167,185,717

 

29,729,717

 

5,784,017

 

264,171,045

 

Vicki L. Sato, Ph.D.

 

1,136,250,748

 

60,677,534

 

5,771,169

 

264,171,045

 

Gerald L. Storch

 

1,136,948,128

 

59,483,754

 

6,267,569

 

264,171,045

 

Togo D. West, Jr.

 

1,139,825,008

 

56,727,655

 

6,146,788

 

264,171,045

 

 

Item 2. The management proposal on the advisory vote to approve the compensation of our named executive officers was approved based upon the following votes:

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-Vote

 

677,656,034

 

515,169,275

 

9,874,142

 

264,171,045

 

 

Item 3. The appointment of Deloitte & Touche LLP as independent registered public accounting firm for the Company for 2015 was ratified based upon the following votes:

 

 

 

 

 

 

 

 

 

For

 

Against

 

Abstain

 

 

 

1,412,919,716

 

47,005,556

 

6,945,224

 

 

 

 

Item 4.  The management proposal to amend the Company’s Amended and Restated Certificate of Incorporation to designate the Delaware Chancery Court as the exclusive forum for certain legal actions was rejected based upon the following votes:

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-Vote

 

813,051,694

 

381,625,346

 

8,022,411

 

264,171,045

 

 

A majority of the outstanding shares was needed for this proposal to be approved.

 

2



 

Item 5.  The management proposal to amend the Company’s Amended and Restated Certificate of Incorporation to remove the supermajority provisions applicable to preferred stockholders was rejected based upon the following votes:

 

All Stockholders

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-Vote

 

1,180,927,557

 

13,101,232

 

8,670,662

 

264,171,045

 

 

Preferred Stockholders

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-Vote

 

1,854

 

190

 

3

 

951

 

 

A majority of the outstanding shares and two-thirds of the outstanding preferred shares were needed for this proposal to be approved.

 

Item 6. The stockholder proposal on shareholder action by written consent was rejected based upon the following votes:

 

 

 

 

 

 

 

Broker

 

For

 

Against

 

Abstain

 

Non-Vote

 

444,118,025

 

746,517,151

 

12,064,275

 

264,171,045

 

 

3



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

BRISTOL-MYERS SQUIBB COMPANY

 

 

 

 

Dated: May 8, 2015

By:

/s/ Sandra Leung

 

 

Name:

Sandra Leung

 

 

Title:

General Counsel and Corporate Secretary

 

4